KH
Kevin Huang CFRA Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Veeva Systems
VEEV
$46.3B
| $282.44 | $208 |
26%
downside
| Hold |
29 May ‘20
5 years ago |
|
2
Regeneron Pharmaceuticals
REGN
$58.9B
| $555.94 | $549 |
1%
downside
| Hold |
27 May ‘20
5 years ago |
|
3
Medtronic
MDT
$119B
| $92.64 | $121 |
31%
upside
| Strong Buy |
21 May ‘20
5 years ago |
|
4
Insulet
PODD
$24.5B
| $347.69 | $179 |
49%
downside
| Sell |
8 May ‘20
5 years ago |
|
5
Becton Dickinson
BDX
$54.6B
| $190.64 | $278 |
46%
upside
| Hold |
8 May ‘20
5 years ago |
|
6
Amgen
AMGN
$151B
| $279.93 | $259 |
7%
downside
| Buy |
1 May ‘20
5 years ago |
|
7
Vertex Pharmaceuticals
VRTX
$101B
| $393.74 | $297 |
25%
downside
| Buy |
30 Apr ‘20
5 years ago |
|
8
Gilead Sciences
GILD
$144B
| $115.70 | $74 |
36%
downside
| Sell |
29 Apr ‘20
5 years ago |
|
9
Edwards Lifesciences
EW
$46.9B
| $79.89 | $77 |
4%
downside
| Buy |
24 Apr ‘20
5 years ago |
|
10
Abbott
ABT
$230B
| $131.95 | $101 |
23%
downside
| Buy |
16 Apr ‘20
5 years ago |
|
11
Boston Scientific
BSX
$160B
| $107.91 | $47 |
56%
downside
| Strong Buy |
9 Mar ‘20
5 years ago |
|
12
DexCom
DXCM
$30.5B
| $77.79 | $64.50 |
17%
downside
| Hold |
14 Feb ‘20
5 years ago |
|
13
CVS Health
CVS
$88.7B
| $69.92 | $86 |
23%
upside
| Strong Buy |
12 Feb ‘20
5 years ago |
|